English | Español

Pfizer
Bree Gonzales | Mar 23, 2022

Pfizer and BioNTech request EUA for additional COVID-19 booster shots for people 65 and older
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Bree Gonzales | Aug 28, 2021

Pfizer’s is the first FDA-approved coronavirus vaccine, and now it has a name: Comirnaty

Harmony Valdoz | Aug 28, 2018

Pharmaceutical industry group backs proposal to share drug savings with Medicare beneficiaries
Press release submission | Apr 28, 2018

PFIZER: MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy
Press release submission | Apr 28, 2018

PFIZER: Pfizer Provides Update on Proposed Trastuzumab Biosimilar
Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval
Carol Ostrow | Dec 26, 2017

Bristol-Myers Squibb, Pfizer, others aim to raise awareness of stroke risk in atrial fibrillation patients

Trending
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 17, 2025

UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+ Pharmaceuticals
Patient Daily | Apr 22, 2025

National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

State Sen. Baldacci: 340B reform ‘could help hospitals alone to the tune of 50 to 70 million per year'